A practical prediction model for determining bevacizumab response and toxicity in the treatment of advanced ovarian and peritoneal cancers - An analysis of GOG 218

被引：3

作者：

Chan, J. ^{[1
]}

Java, J. ^{[2
]}

Monk, B. ^{[3
]}

Alvarez-Secord, A. ^{[4
]}

Kapp, D. ^{[5
]}

Birrer, M. ^{[6
]}

Aghajanian, C. ^{[7
]}

Bookman, M. ^{[8
]}

Kattan, M. ^{[9
]}

Burger, R. ^{[10
]}

机构：

[1] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA

[2] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[3] Creighton Univ, Sch Med, Phoenix, AZ USA

[4] Duke Univ, Med Ctr, Durham, NC USA

[5] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[6] Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02115 USA

[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[8] Univ Arizona, Ctr Canc, Tucson, AZ USA

[9] Cleveland Clin, Cleveland, OH 44106 USA

[10] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

来源：

关键词：

D O I：

10.1016/j.ygyno.2011.12.070

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S31 / S31

页数：1